Pre-clinical testing of malignant fibroblast activation protein-specific re-directed T cells for treatment of pleural mesothelioma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-1426
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Pre-clinical testing of malignant fibroblast activation protein-specific re-directed T cells for treatment of pleural mesothelioma ; volume:1 ; number:1 ; day:7 ; month:11 ; year:2013 ; pages:1 ; date:11.2013
Journal for ImmunoTherapy of Cancer ; 1, Heft 1 (7.11.2013), 1, 11.2013
- Creator
-
Schuberth, Petra C.
- Contributor
-
Hagedorn, Christian
Jensen, Shawn M.
Gulati, Pratiksha
Marroquin Belaunzaran, Osiris
Soltermann, Alex
Jüngel, Astrid
Renner, Christoph
Petrausch, Ulf
SpringerLink (Online service)
- DOI
-
10.1186/2051-1426-1-S1-P35
- URN
-
urn:nbn:de:1111-2016072651215
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Schuberth, Petra C.
- Hagedorn, Christian
- Jensen, Shawn M.
- Gulati, Pratiksha
- Marroquin Belaunzaran, Osiris
- Soltermann, Alex
- Jüngel, Astrid
- Renner, Christoph
- Petrausch, Ulf
- SpringerLink (Online service)
Other Objects (12)
Treatment of malignant pleural mesothelioma by fibroblast activation protein-specific re-directed T cells
Re-directed T cells for the treatment of fibroblast activation protein (FAP)-positive malignant pleural mesothelioma (FAPME-1)
ADAM10 mediates malignant pleural mesothelioma invasiveness
Early detection of malignant pleural mesothelioma
KRAS signaling in malignant pleural mesothelioma
Molecular biological analysis of malignant pleural mesothelioma
The combination of sorafenib and everolimus shows antitumor activity in preclinical models of malignant pleural mesothelioma
Genomic Landscape of Pleural Mesothelioma and Therapeutic Aftermaths
Genomic landscape of pleural and peritoneal mesothelioma tumours
Correlation between pleural fluid cytology and magnitude of pleural invasion in patients with malignant pleural mesothelioma
Therapeutic potential of targeting S100A11 in malignant pleural mesothelioma
Exceptional Regression of Malignant Pleural Mesothelioma with Pembrolizumab Monotherapy
Treatment of malignant pleural mesothelioma by fibroblast activation protein-specific re-directed T cells
Re-directed T cells for the treatment of fibroblast activation protein (FAP)-positive malignant pleural mesothelioma (FAPME-1)
ADAM10 mediates malignant pleural mesothelioma invasiveness
Early detection of malignant pleural mesothelioma
KRAS signaling in malignant pleural mesothelioma
Molecular biological analysis of malignant pleural mesothelioma
The combination of sorafenib and everolimus shows antitumor activity in preclinical models of malignant pleural mesothelioma
Genomic Landscape of Pleural Mesothelioma and Therapeutic Aftermaths
Genomic landscape of pleural and peritoneal mesothelioma tumours
Correlation between pleural fluid cytology and magnitude of pleural invasion in patients with malignant pleural mesothelioma
Therapeutic potential of targeting S100A11 in malignant pleural mesothelioma
Exceptional Regression of Malignant Pleural Mesothelioma with Pembrolizumab Monotherapy
Treatment of malignant pleural mesothelioma by fibroblast activation protein-specific re-directed T cells
Re-directed T cells for the treatment of fibroblast activation protein (FAP)-positive malignant pleural mesothelioma (FAPME-1)
ADAM10 mediates malignant pleural mesothelioma invasiveness
Early detection of malignant pleural mesothelioma
KRAS signaling in malignant pleural mesothelioma
Molecular biological analysis of malignant pleural mesothelioma
The combination of sorafenib and everolimus shows antitumor activity in preclinical models of malignant pleural mesothelioma
Genomic Landscape of Pleural Mesothelioma and Therapeutic Aftermaths
Genomic landscape of pleural and peritoneal mesothelioma tumours
Correlation between pleural fluid cytology and magnitude of pleural invasion in patients with malignant pleural mesothelioma
Therapeutic potential of targeting S100A11 in malignant pleural mesothelioma